TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
JSPR

Jasper Therapeutics Inc

Healthcare · Biotechnology

0.6178$ -2.6% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet JSPR
Line item 2019 2020 2021 2022 2023 2024 2025
-14.2% +301.0% -48.4% +96.2% -15.8% -55.2%
-23.8% +324.6% -52.5% +113.1% -14.8% -54.3%
-27.0% +327.0% -54.8% +127.2% -17.6% -59.9%
-27.0% +327.0% -54.8% +127.2% -17.6% -59.9%
+16.3% +66.0% -78.4%
-674.0%
+138.2% -26.2%
+857.4% -58.7% -48.7% +33.0% +10.8% +73.5%
+101.3% +99.9% -11.9% +75.1% +23.1% -13.4%
+71.3% +12.4% +12.0% +13.4%
+127.4% +176.6% -54.9% +134.7% -2.9% +54.5%
-266.5% -48.2% +118.0% -21.4% -93.3%
-1.7% +558.7% +220.2% +186.1% +39.7% +31.4%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?